Ronald Richard insider trades: Emergent BioSolutions (EBS) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Ronald reports to the SEC
Open-market buys and sales
24 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 5, 2025 | EBS | ↓ Sell | 21,984 | $11.97 | $263K | Direct | Dec 9, 2025 (4d) |
| Nov 25, 2022 | EBS | ↓ Sell | 1,912 | $11.94 | $23K | Direct | Nov 29, 2022 (4d) |
| Aug 7, 2020 | EBS | ↓ Sell | 6,297 | $131.00 | $825K | Direct | Aug 11, 2020 (4d) |
| Jun 3, 2020 | EBS | ↓ Sell | 6,572 | $87.51 | $575K | Direct | Jun 5, 2020 (2d) |
| May 5, 2020 | EBS | ↓ Sell | 8,375 | $80.19 | $672K | Direct | May 6, 2020 (1d) |
| Apr 27, 2020 | EBS | ↓ Sell10b5-1 | 7,893 | $78.00 | $616K | Direct | Apr 29, 2020 (2d) |
| Feb 21, 2020 | EBS | ↓ Sell10b5-1 | 5,152 | $65.00 | $335K | Direct | Feb 25, 2020 (4d) |
| Nov 7, 2019 | EBS | ↓ Sell10b5-1 | 5,153 | $60.00 | $309K | Direct | Nov 12, 2019 (5d) |
| Nov 7, 2018 | EBS | ↓ Sell10b5-1 | 7,893 | $70.00 | $553K | Direct | Nov 8, 2018 (1d) |
| Aug 21, 2018 | EBS | ↓ Sell10b5-1 | 7,893 | $60.02 | $474K | Direct | Aug 23, 2018 (2d) |
| Jun 6, 2018 | EBS | ↓ Sell | 7,342 | $53.00 | $389K | Direct | Jun 7, 2018 (1d) |
| Apr 17, 2018 | EBS | ↓ Sell10b5-1 | 7,893 | $55.00 | $434K | Direct | Apr 19, 2018 (2d) |
| Dec 12, 2017 | EBS | ↓ Sell10b5-1 | 23,681 | $45.02 | $1.1M | Direct | Dec 13, 2017 (1d) |
| Sep 28, 2017 | EBS | ↓ Sell10b5-1 | 23,681 | $40.00 | $947K | Direct | Sep 29, 2017 (1d) |
| Dec 13, 2016 | EBS | ↓ Sell | 5,900 | $34.09 | $201K | Direct | Dec 15, 2016 (2d) |
| Dec 30, 2015 | EBS | ↓ Sell | 21,600 | $40.00 | $864K | Direct | Jan 4, 2016 (5d) |
| Aug 13, 2015 | EBS | ↓ Sell | 4,922 | $36.00 | $177K | Direct | Aug 13, 2015 (0d) |
| Jul 13, 2015 | EBS | ↓ Sell | 4,922 | $34.00 | $167K | Direct | Jul 13, 2015 (0d) |
| Jun 29, 2015 | EBS | ↓ Sell | 4,923 | $32.76 | $161K | Direct | Jul 1, 2015 (2d) |
| Dec 26, 2014 | EBS | ↓ Sell | 5,000 | $28.00 | $140K | Direct | Dec 29, 2014 (3d) |
| Dec 17, 2014 | EBS | ↓ Sell | 5,000 | $27.00 | $135K | Direct | Dec 19, 2014 (2d) |
| Oct 20, 2008 | EBS | ↓ Sell10b5-1 | 10,000 | $17.91 | $179K | Direct | Oct 21, 2008 (1d) |
| Oct 17, 2008 | EBS | ↓ Sell10b5-1 | 23,156 | $16.85 | $390K | Direct | Oct 20, 2008 (3d) |
| May 5, 2008 | EBS | ↓ Sell | 10,000 | $9.99 | $100K | Direct | May 7, 2008 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EBS insiders
Open-market trades in the last 12 months
About Ronald Richard's insider trades
Ronald Richard is a director at Emergent BioSolutions (EBS). Since May 5, 2008, Ronald has reported no open-market purchases and 24 sales worth $10.0M on SEC Form 4. In the last 12 months: 1 sale ($263K).
10 sales (53% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (19 filings), option exercises (15 filings), other transactions (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EBS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.